Sign inGet started

Lux Co-Invest Partners, LLC

Insider CIK 1722021 · RXRX 10% owner · AEVA 10% owner · SNCE 10% owner · LTCH 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AEVA Aeva Technologies, Inc. J Other2022-08-052022-08-097,346,159— $014,692,316SEC↗
SNCE Science 37 Holdings, Inc. J Other2022-04-042022-04-062,914,667— $08,743,999SEC↗
RXRX RECURSION PHARMACEUTICALS, J Other2021-12-072021-12-094,265,576— $013,021,519SEC↗
LTCH Latch, Inc. J Other2021-09-282021-10-051,358,164— $04,084,493SEC↗
LTCH Latch, Inc. J Other2021-09-282021-10-052,409,489— $07,228,469SEC↗
AEVA Aeva Technologies, Inc. J Other2021-09-082021-09-107,346,159— $022,038,475SEC↗
RXRX RECURSION PHARMACEUTICALS, C Conversion deriv2021-04-202021-04-2010,279,275— $00SEC↗
RXRX RECURSION PHARMACEUTICALS, C Conversion deriv2021-04-202021-04-203,578,653— $00SEC↗
RXRX RECURSION PHARMACEUTICALS, C Conversion deriv2021-04-202021-04-201,490,783— $00SEC↗
RXRX RECURSION PHARMACEUTICALS, C Conversion deriv2021-04-202021-04-201,825,883— $00SEC↗
RXRX RECURSION PHARMACEUTICALS, C Conversion2021-04-202021-04-2017,174,594— $017,187,095SEC↗
RXRX RECURSION PHARMACEUTICALS, C Conversion2021-04-202021-04-2017,187,095— $00SEC↗
RXRX RECURSION PHARMACEUTICALS, C Conversion2021-04-202021-04-2017,187,095— $017,287,095SEC↗
RXRX RECURSION PHARMACEUTICALS, P Buy2021-04-162021-04-20100,000$18.00 $1.80M100,000SEC↗